Title : AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance.

Pub. Date : 2003 Jun 27

PMID : 12697749






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance. Cisplatin mitogen-activated protein kinase kinase kinase 5 Homo sapiens
2 Here we demonstrate that constitutively active AKT2 renders cisplatin-sensitive A2780S ovarian cancer cells resistant to cisplatin, whereas phosphatidylinositol 3-kinase inhibitor or dominant negative AKT2 sensitizes A2780S and cisplatin-resistant A2780CP cells to cisplatin-induced apoptosis through regulation of the ASK1/JNK/p38 pathway. Cisplatin mitogen-activated protein kinase kinase kinase 5 Homo sapiens
3 AKT2 interacts with and phosphorylates ASK1 at Ser-83 resulting in inhibition of its kinase activity. Serine mitogen-activated protein kinase kinase kinase 5 Homo sapiens
4 Expression of nonphosphorylatable ASK1-S83A overrode the AKT2-inhibited JNK/p38 activity and Bax conformational changes, whereas phosphomimic ASK1-S83D inhibited the effects of cisplatin on JNK/p38 and Bax. Cisplatin mitogen-activated protein kinase kinase kinase 5 Homo sapiens
5 In conclusion, our data indicate that AKT2 inhibits cisplatin-induced JNK/p38 and Bax activation through phosphorylation of ASK1 and thus, plays an important role in chemoresistance. Cisplatin mitogen-activated protein kinase kinase kinase 5 Homo sapiens